Answers are grounded in this paper and cite their sources.
Background This study aimed to investigate the associations of recurrent acute pancreatitis (RAP) and obesity with post-pancreatitis diabetes mellitus (PPDM), including their joint exposure and interaction. Methods This single-center retrospective cohort included patients hospitalized for pancreatitis from January 2020 to January 2023. Of 864 screened patients, 721 met eligibility criteria: 408 with first-episode acute pancreatitis (First AP), 278 with RAP, and 35 with chronic pancreatitis. The primary analysis included 686 patients with First AP or RAP. Obesity was defined as body mass index (BMI) ≥28 kg/m², and PPDM was ascertained as a new diagnosis of diabetes during follow-up. Missing data were handled by multiple imputation. Multivariable logistic regression assessed RAP, obesity, and their joint exposure with adjustment for age, sex, pancreatitis etiology, and follow-up duration. BMI was also analyzed continuously using restricted cubic splines (RCS). Additive and multiplicative interactions and sensitivity analyses were performed. Results Among 686 patients, 62 developed PPDM (9.0%). RAP (adjusted odds ratio [aOR] 2.93, 95% confidence interval [CI] 1.65–5.21; P < 0.001) and obesity (aOR 2.11, 95% CI 1.13–3.95; P = 0.019) were independently associated with PPDM. Using First AP + non-obese as the reference, aORs were 2.33 (95% CI 0.96–5.63) for First AP + obese, 3.11 (1.53–6.34) for RAP + non-obese, and 6.08 (2.39–15.43) for RAP + obese. Each 1-kg/m² and 5-kg/m² increase in BMI was associated with aORs of 1.14 (1.06–1.22) and 1.88 (1.31–2.71), respectively (both P < 0.001). RCS showed an overall association between BMI and PPDM (P for overall association = 0.004) without evidence of nonlinearity (P for nonlinearity = 0.287). No evidence of additive or multiplicative interaction was observed (multiplicative interaction OR 0.84, 95% CI 0.26–2.74; P = 0.773; RERI 1.03, 95% CI −2.30 to 4.36; P = 0.543). Findings were stable across sensitivity analyses. Conclusions RAP and obesity were independently associated with PPDM, and higher BMI was also associated with PPDM. The RAP + obese group had the largest effect estimate. Patients with both a history of RAP and obesity may warrant particular attention during long-term glycemic follow-up.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: